• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STIMWAVE TECHNOLOGIES INC. STIMQ NEUROSTIMULATOR; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STIMWAVE TECHNOLOGIES INC. STIMQ NEUROSTIMULATOR; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number STQ4-RCV-A0
Device Problem Material Erosion (1214)
Patient Problems Post Operative Wound Infection (2446); Skin Inflammation/ Irritation (4545)
Event Date 12/29/2020
Event Type  Injury  
Manufacturer Narrative
On (b)(6) 2021, the clinical representative became aware that a recently implanted patient was experiencing an infection at the wound site after a revision was performed to correct an erosion.The implanting clinician confirmed an infection was present and treated the patient with antibiotics (name, dosage, frequency unknown).The clinical representative confirmed the patient completed the antibiotic treatment and the infection is clear.However, the patient is completing about a new pain in her leg and wants to have the stimulator explanted.The implanting clinician has explained to the patient that the new pain is not related to the stimulator.However, the patient is adamant about an explant.The clinical representative confirmed that the implant procedure was performed in a sterile environment, sterile field handling protocols were used, the procedure was completed in accordance with the product instructions for use, and the sterile barriers of all products used were intact before the implant.A stimwave representative reviewed sterilization and packaging records for the respective product lot and was able to confirm that the product was delivered sterile, sterilized using validated sterilization parameters, and sterile barriers were verified to be intact following packaging.Based on this information, the infection was confirmed/replicated.There is no evidence that the product did not meet specifications, and the stimulator is used to treat pain.The cause of the infection is unknown/no problem found.
 
Event Description
On (b)(6) 2021, the clinical representative became aware that a recently implanted patient was experiencing an infection at the wound site after a revision was performed to correct an erosion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STIMQ NEUROSTIMULATOR
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer (Section G)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer Contact
andrea najera
1310 park central boulevard s.
pompano beach, FL 33064
8009655134
MDR Report Key11389563
MDR Text Key233946745
Report Number3010676138-2021-00019
Device Sequence Number1
Product Code GZF
UDI-Device Identifier00818225020464
UDI-Public010081822502046417220901
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial
Report Date 01/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date09/01/2022
Device Model NumberSTQ4-RCV-A0
Device Lot NumberSWO200929
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/28/2021
Initial Date FDA Received02/27/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-